Elias Mossialos is Brian Abel-Smith Professor of Health Policy and Director of LSE Health. He was the founding Head of the Department of Health Policy. His primary research focus revolves around health systems and policy, with a particular emphasis on issues related to healthcare financing, accessibility, quality, regulation, pharmaceutical policies, AMR, and cancer care and policy. He has developed the Options Market for Antibiotics, an incentive scheme to stimulate research and development (R&D). His work has been translated into Japanese, Russian, Greek, and Spanish, comprising over 300 publications across the fields of public policy, health policy and economics, and political science.
In 2010 he was awarded the Andrija Stampar medal by the Association of Schools of Public Health in Europe (ASPHER) and the European Public Health Association (EUPHA), for contributions to European public health. He received the 2021 Choice award by the Association of US College and Research Libraries (ACRL) for Outstanding Academic Title, the 2002 and 2007 Baxter Awards from the European Health Management Association for the best publication in health policy and management in Europe, the 2022 Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research, and a Commended Prize in the 2002 BMA Medical Book Competition. In 2009, under his directorship, LSE Health was honoured with the biennial Queen's Anniversary Prize for Higher and Further Education in the UK.
In 1998, Professor Mossialos co-founded the European Observatory on Health Systems and Policies, a major health policy research and knowledge transfer programme and a partnership between the World Health Organization Regional Office for Europe, the European Commission, the Governments of Austria, Belgium, Finland, Ireland, The Netherlands, Norway, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom, the French National Health Insurance Fund (Caisse nationale de l'assurance maladie des travailleurs salariés), the Veneto Region of Italy, the Health Foundation, the LSE and LSHTM. He is currently Co-Director of the Observatory.
He has been profiled in both the Lancet and BMJ, and co-chaired the LSE-Lancet Commission on the future of the UK NHS and the WHO Review Panel of the Overall programme review of the global strategy and plan of action on public health, innovation and intellectual property.
He has direct experience of government, having served in Greece as a Member of Parliament (2009-12) and as Minister of State (2011) and chaired the Parliament's Special Permanent Committee on Monitoring the Social Security System. Professor Mossialos has been an active participant in policy debates, advising the World Health Organization, the European Parliament, the European Commission, the World Bank, the UK Office of Fair Trading, Ministries of Health and Social Affairs in Austria, Belgium, Brazil, China, Cyprus, Finland, Greece, Ireland, Kazakhstan, Kuwait, The Netherlands, Russia, Singapore, Slovenia, South Africa, Spain and Sweden and health insurance funds in Croatia, France, Hungary and South Korea. He was a member of the management board of the European Medicines Agency (2000-2003) and contributed to the work of the International Forum on 'Common access to health care services' co-ordinated by the health ministers of Sweden, the UK and New Zealand. He served as a senior adviser during the Belgian Presidency of the EU Council in both 2001 and 2010, with a primary focus on the impact of EU law on health systems. He also contributed his expertise during the Swedish Presidencies in 2009 and 2023, as well as the Dutch Presidency in 2016, with a particular emphasis on addressing Antimicrobial Resistance.
He has recently provided guidance to the World Health Organization Regional Office for Europe concerning their responses to Covid-19. He was also engaged by the State Council in China to advise on pharmaceutical policy reform. In addition, he has offered his insights to the Austrian government regarding health insurance reform. Currently, he holds the position of senior fellow to the Ministry of Health in Singapore, where he is contributing to healthcare reform initiatives.
In 2020-21 he was the Scientific Director of the Pan-European Commission on Health and Sustainable Development, an independent group of leaders convened by the WHO, chaired by the former Italian Prime Minister Mario Monti, to rethink policy priorities in the light of pandemics.
Professor Mossialos established the MSc in International Health Policy at LSE in 1999, and in 2009 he developed a modular MSc in Health Economics, Policy and Management directed at mid-career professionals who lack the flexibility to participate in a traditional MSc programme. In 2014, in collaboration with the European Society of Cardiology, he established a modular MSc in Health Economics, Outcomes and Management. In 2014, he established an interdisciplinary MSc in Global Health, and in 2018 he launched an Executive MSc in Health Policy in co-operation with the University of Chicago.
Current teaching: HP400 Financing Health Care
Department of Health Policy
Director, LSE Health
Co-Director, European Observatory on Health Systems and Policies